Description
PP17 Targeting of the histone methyltransferases G9a and GLP in multiple myeloma
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: PP17 Targeting of the histone methyltransferases G9a and GLP in multiple myeloma
€3.03
